Timothy K. McDaniel, Ph.D., serves as Sr. Vice President of Emerging Opportunities. In this role, Dr. McDaniel works with TGen’s faculty and administrative leadership to expand the impact of the institute’s technology and know-how, through business development, external alliances, and clinical operations support.
Dr. McDaniel came to TGen from PMed Management, L.L.C., where he served as Executive Vice President and General Manager of Ashion Analytics, a clinical genomics laboratory. Prior to that, he worked at Illumina, Inc., where he served in a variety of roles in R&D, quality, product development, and clinical laboratory development. In these roles he was an early member of the team that grew Illumina from a privately held startup with no products to a $20 billion leader in genomics technology.
Dr. McDaniel has extensive experience in genomics, cancer biology, infectious disease, bioinformatics, technology development, clinical lab development, and commercialization of scientifically based products and services. He received a B.A. in Biological Sciences from UC Santa Barbara, a Ph.D. in Molecular and Cell Biology from the University of Maryland, Baltimore, and was a Damon Runyon Cancer Research Foundation Postdoctoral Fellow at Stanford Medical School.